Financhill
Back

Agenus, Inc. 10K Form

Sell
36

AGEN
Agenus, Inc.

Last Price:
$3.34
Seasonality Move:
23.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive AGEN News And Ratings

See the #1 stock for the next 7 days that we like better than AGEN

AGEN Financial Statistics

Sales & Book Value

Annual Sales: $114.2M
Cash Flow: $-16.6M
Price / Cash Flow: 0
Annual Sales: $-7.68
Price / Book: 0

Profitability

EPS (TTM): -0.38850
Net Income (TTM): $-3.1M
Gross Margin: $103.2M
Return on Equity: 0%
Return on Assets: -1.44%

Agenus, Inc. Earnings Forecast

Key Agenus, Inc. Financial Ratios

  • The Gross Profit Margin over the past 26 years for AGEN is 90.35%.
  • The Selling, General & Administrative Expenses for AGEN have been equal to 47.63% of Gross Profit Margin.
  • The Research & Development expenses have been 69.48% of Revenue.
  • The Net Earning history of AGEN is -2.70% of Total Revenues.
  • Per Share Earnings over the last 27 years have been positive in 16 years.

Agenus, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: AGEN
CUSIP: 00847G
Website: agenusbio.com

Debt

Debt-to-Equity Ratio: -1.24
Current Ratio: 0.41
Quick Ratio: 0.03

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 1.6

AGEN Technical Analysis vs Fundamental Analysis

Sell
36
Agenus, Inc. (AGEN) is a Sell

Is Agenus, Inc. a Buy or a Sell?

  • Agenus, Inc. stock is rated a Sell
    The current Agenus, Inc. [AGEN] share price is $3.33. The Score for AGEN is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.